Actively Recruiting
Stepped Care Cognitive Behavioral Therapy for Children and Adolescents With Anxiety
Led by Andrew Wiese · Updated on 2026-03-02
106
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
Sponsors
A
Andrew Wiese
Lead Sponsor
B
Baylor College of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying childhood anxiety disorders CAD, which are common and can affect school, friendships, and family life. This trial focuses on a stepped care model that starts with parent-focused treatment to help children with anxiety. The study aims to improve access to effective care by testing a low-intensity, affordable approach that involves parents, addressing barriers like limited providers and high costs. The study compares two treatments Relaxation and Mentorship Training RMT, which includes 14 sessions of relaxation techniques and writing activities, and Stepped Care Targeting Exposure and Parenting for Anxiety STEP-A. STEP-A involves two steps first, parents read a book and attend four therapy sessions while practicing tasks with their child, then responders receive 10 weeks of family-based cognitive behavioral therapy focused on exposures and increasing parental involvement. Participants aged 7 to 17 with diagnosed anxiety disorders will attend therapy sessions and be assessed at multiple time points using anxiety rating scales and clinical interviews. Researchers will track progress before, during, and after treatment, including follow-ups at one month and longer-term caregiver interviews. The study runs until 2028 and seeks to better understand how stepped care works and its benefits for children with anxiety.
CONDITIONS
Brief Title
Stepped Care Treatment for Anxiety Resilience
Who Can Participate
Eligibility Criteria
You may qualify if you...
- A primary diagnosis of OCD or an anxiety disorder including separation anxiety disorder, social phobia, generalized anxiety disorder, specific phobia, agoraphobia, or panic disorder determined by a diagnostic interview.
- A score of 14 or higher on the Pediatric Anxiety Rating Scale indicating clinically significant anxiety.
- Child is between 7 and 17 years old.
- Residence in Texas and plan to stay in Texas during treatment sessions.
You will not qualify if you...
- Psychosis, cognitive disability, or any condition limiting caregiver's ability to follow instructions.
- Parent substance use disorder within the past 3 months.
- Child or parent is suicidal; delayed entry possible after stabilization for more than 6 months.
- Recent changes or initiation of psychotropic medications within specified time frames before enrollment; medications must remain stable during treatment.
Research Team
A
Andrew D Wiese, PhD
J
Jazzmine Ward, BS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here